AtriCure, Inc.

ATRC Healthcare Medical Instruments & Supplies

AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 12.8%, EPS grew 238.5%, free cash flow fell 2.79% and total debt fell 4.43%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

56.09 1.69 −2.92%
Market cap
$2.9B
P/E
259×
Fwd P/E
591×
Dividend yield
—
F-score
7/9
Altman Z
7.31
Beneish M
−2.91
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
129.18 0.00 0.00 0.00

+8 more quarters

P/S ratio
2.39 2.50 3.53 3.26
P/FCF ratio
58.91 58.32 103.31 562.68
P/Operating CF
61.36 (345.09) 94.32 63.23
P/B ratio
2.64 2.80 3.84 3.54
EV/Sales
2.26 2.40 3.40 3.16
EV/EBITDA
37.60 72.75 157.03 0.00
EV/FCF
55.62 56.05 99.30 544.89
Current Ratio
4.22 4.29 3.96 3.87
Net Debt/EBITDA
(6.42) (12.60) (12.19) (13.49)
Debt/Equity
0.14 0.15 0.15 0.15
Earnings Yield
0.77% (0.33%) (0.60%) (1.72%)
Free Cash Flow Yield
1.70% 1.71% 0.97% 0.18%
Free Cash Flow per Share
0.38 (0.16) 0.39 0.50
Book value per Share
10.61 10.17 10.30 9.94
Free Cash Flow
18.43 (7.85) 18.43 24.11
EV/EBIT
99.74 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates